Status report from the American acne & rosacea society on medical management of acne in adult women, part 3: Oral therapies

James Q. Del Rosso, Julie C. Harper, Emmy M. Graber, Diane Thiboutot, Nanette B. Silverberg, Lawrence F. Eichenfield

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Parts 1 and 2 of this 3-part series provided an overview of the epidemiology, visible patterns, and important considerations for clinical and laboratory evaluation of acne vulgaris (AV) in adult women and reviewed the role of proper skin care and topical therapies in this patient population. In Part 3, oral therapies including combination oral contraceptives, spironolactone, antibiotics, and isotretinoin are discussed along with important considerations that clinicians should keep in mind when selecting oral agents for management of AV in adult women.

Original languageEnglish (US)
Pages (from-to)376-382
Number of pages7
JournalCutis
Volume96
Issue number6
StatePublished - Jan 1 2015

Fingerprint

Rosacea
Medical Societies
Acne Vulgaris
Skin Care
Isotretinoin
Spironolactone
Oral Contraceptives
Epidemiology
Anti-Bacterial Agents
Therapeutics
Population
Adult Acne

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Del Rosso, J. Q., Harper, J. C., Graber, E. M., Thiboutot, D., Silverberg, N. B., & Eichenfield, L. F. (2015). Status report from the American acne & rosacea society on medical management of acne in adult women, part 3: Oral therapies. Cutis, 96(6), 376-382.
Del Rosso, James Q. ; Harper, Julie C. ; Graber, Emmy M. ; Thiboutot, Diane ; Silverberg, Nanette B. ; Eichenfield, Lawrence F. / Status report from the American acne & rosacea society on medical management of acne in adult women, part 3 : Oral therapies. In: Cutis. 2015 ; Vol. 96, No. 6. pp. 376-382.
@article{c0e5a1b51b88468da9295ed08489c24e,
title = "Status report from the American acne & rosacea society on medical management of acne in adult women, part 3: Oral therapies",
abstract = "Parts 1 and 2 of this 3-part series provided an overview of the epidemiology, visible patterns, and important considerations for clinical and laboratory evaluation of acne vulgaris (AV) in adult women and reviewed the role of proper skin care and topical therapies in this patient population. In Part 3, oral therapies including combination oral contraceptives, spironolactone, antibiotics, and isotretinoin are discussed along with important considerations that clinicians should keep in mind when selecting oral agents for management of AV in adult women.",
author = "{Del Rosso}, {James Q.} and Harper, {Julie C.} and Graber, {Emmy M.} and Diane Thiboutot and Silverberg, {Nanette B.} and Eichenfield, {Lawrence F.}",
year = "2015",
month = "1",
day = "1",
language = "English (US)",
volume = "96",
pages = "376--382",
journal = "Cutis",
issn = "0011-4162",
publisher = "Quadrant Healthcom Inc.",
number = "6",

}

Del Rosso, JQ, Harper, JC, Graber, EM, Thiboutot, D, Silverberg, NB & Eichenfield, LF 2015, 'Status report from the American acne & rosacea society on medical management of acne in adult women, part 3: Oral therapies', Cutis, vol. 96, no. 6, pp. 376-382.

Status report from the American acne & rosacea society on medical management of acne in adult women, part 3 : Oral therapies. / Del Rosso, James Q.; Harper, Julie C.; Graber, Emmy M.; Thiboutot, Diane; Silverberg, Nanette B.; Eichenfield, Lawrence F.

In: Cutis, Vol. 96, No. 6, 01.01.2015, p. 376-382.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Status report from the American acne & rosacea society on medical management of acne in adult women, part 3

T2 - Oral therapies

AU - Del Rosso, James Q.

AU - Harper, Julie C.

AU - Graber, Emmy M.

AU - Thiboutot, Diane

AU - Silverberg, Nanette B.

AU - Eichenfield, Lawrence F.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Parts 1 and 2 of this 3-part series provided an overview of the epidemiology, visible patterns, and important considerations for clinical and laboratory evaluation of acne vulgaris (AV) in adult women and reviewed the role of proper skin care and topical therapies in this patient population. In Part 3, oral therapies including combination oral contraceptives, spironolactone, antibiotics, and isotretinoin are discussed along with important considerations that clinicians should keep in mind when selecting oral agents for management of AV in adult women.

AB - Parts 1 and 2 of this 3-part series provided an overview of the epidemiology, visible patterns, and important considerations for clinical and laboratory evaluation of acne vulgaris (AV) in adult women and reviewed the role of proper skin care and topical therapies in this patient population. In Part 3, oral therapies including combination oral contraceptives, spironolactone, antibiotics, and isotretinoin are discussed along with important considerations that clinicians should keep in mind when selecting oral agents for management of AV in adult women.

UR - http://www.scopus.com/inward/record.url?scp=85011263125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011263125&partnerID=8YFLogxK

M3 - Review article

C2 - 26761932

AN - SCOPUS:85011263125

VL - 96

SP - 376

EP - 382

JO - Cutis

JF - Cutis

SN - 0011-4162

IS - 6

ER -

Del Rosso JQ, Harper JC, Graber EM, Thiboutot D, Silverberg NB, Eichenfield LF. Status report from the American acne & rosacea society on medical management of acne in adult women, part 3: Oral therapies. Cutis. 2015 Jan 1;96(6):376-382.